- What is CATHETRIX's primary business?
- CATHETRIX is a medical device company that develops and produces smart catheter fixations and delivers safety solutions for hospital and home care.
- What is CATHETRIX's flagship product?
- CATHETRIX's flagship product is FOLY/SAFE 2.0, a Foley catheter stabilizer designed to prevent accidental urinary catheter extraction and minimize movement, thereby reducing the risk of Catheter Associated Urinary Tract Infection (CAUTI).
- How does FOLY/SAFE 2.0 prevent harm during catheter extraction?
- If the Foley catheter is extracted with excessive force, FOLY/SAFE 2.0 will cut the sterile fluid tube, allowing the retention balloon to deflate and the catheter to slide out safely, preventing damage to the bladder and urethra.
- When was CATHETRIX founded?
- CATHETRIX was founded in July 2013.
- Where is CATHETRIX headquartered?
- CATHETRIX is headquartered in Tel Aviv-Yafo, Israel.
- What is CATHETRIX's current employee count?
- CATHETRIX has an employee count in the 1-10 range.
- In which sector does CATHETRIX primarily operate?
- CATHETRIX primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- Does CATHETRIX hold any patents?
- Yes, CATHETRIX holds one patent.